Literature DB >> 9824990

[Heart failure as clinical onset of essential mixed cryoglobulinemia].

G Bragagni1, A Baldini, M Bianconcini.   

Abstract

The case of a 58-year old man affected by heart failure on ischemic basis, as clinical onset of essential mixed cryoglobulinemia (EMC) is reported. Laboratory assays, ECG at rest and exercise electrocardiogram, echocardiogram, myocardial scintigraphy, cardiac catheterization with coronarography, hepatic, bone and kidney biopsies confirmed the diagnosis. Cases of primitive heart involvement are rarely reported and are, usually, due to myocardial infarction. Nevertheless in the published series of cases, heart failure is often coupled with EMC and, not seldom, is the cause of death. In the present case heart failure was the dominant element of clinical symptomatology and wasn't consequent to renal involvement or hypertension, but was sustained by a myocardial contractile deficiency, on ischemic basis, with undamaged coronary circle at angiography. Therefore heart failure was ascribed to an involvement of coronary microcirculation in the course of systemic vasculitis.

Entities:  

Mesh:

Year:  1998        PMID: 9824990

Source DB:  PubMed          Journal:  Minerva Med        ISSN: 0026-4806            Impact factor:   4.806


  3 in total

1.  High circulating N-terminal pro-brain natriuretic peptide and tumor necrosis factor-alpha in mixed cryoglobulinemia.

Authors:  Alessandro Antonelli; Clodoveo Ferri; Silvia-Martina Ferrari; Fabio Galetta; Ferdinando Franzoni; Gino Santoro; Salvatore De Marco; Emiliano Ghiri; Poupak Fallahi
Journal:  World J Gastroenterol       Date:  2009-10-28       Impact factor: 5.742

2.  Vasculitic emergencies in the intensive care unit: a special focus on cryoglobulinemic vasculitis.

Authors:  Mohamad Zaidan; Eric Mariotte; Lionel Galicier; Bertrand Arnulf; Véronique Meignin; Jérôme Vérine; Alfred Mahr; Elie Azoulay
Journal:  Ann Intensive Care       Date:  2012-07-19       Impact factor: 6.925

Review 3.  [Vasculitis associated with viral infections].

Authors:  Pascal Cohen; Loïc Guillevin
Journal:  Presse Med       Date:  2004-11-06       Impact factor: 1.228

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.